Infection is one of the leading causes of morbidity and mortality in the elderly. Streptococcus pneumoniae is the organism most commonly isolated from elderly patients with pneumonia. Increased susceptibility to infections that occur in the elderly has been attributed to deteriorating health, decreased pulmonary function and a functional decline of the immune system. The immune system is unique in that it may be manipulated to achieve a desirable response. Studies in aged mice demonstrate both quantitative and qualitative changes in the immune response to T-independent type 2 (TI-2) antigens. Reports indicate age related loss of affinity, fine specificity and protective immunity are associated with a molecular shift in V gene usage and changes in cytokine profile. Studies of the in vivo immune response in elderly have been limited to vaccine efficacy studies and quantitative analysis of the magnitude and duration of the post-vaccination antibody response. The results of these studies suggest that despite adequate quantitative immune response the elderly show decreased vaccine efficacy. Current knowledge concerning the aging immune response to TI-2 antigens is mostly based on animal models and may not be applicable to humans. Human studies are fragmented and address quantitative and qualitative immune response as separate issues. We propose to study and characterize the immune response to S. pneumoniae capsular polysaccharide in the elderly. We will focus on both quantitative and qualitative changes in the immune response on molecular and functional levels. The quantitative immune response, isotype and IgG subclass, will be correlated with opsonophagocytic activity. We hypothesize that the discrepancy between the quantitative and qualitative immune response in the elderly results from altered V region sequence. We will characterize the immunoglobulin gene usage pattern and V-D-J joint diversity of the antibody response to pneumococcal polysaccharides (PPS) of serotypes 4 and 14 in elderly and young adults. This will be accomplished by gene family specific ELISA and by isolating single responding cells and determining the sequence of the V chains. Second, we propose to evaluate the influence of soluble regulatory factors on the aging immune response. The reconstituted SCID mouse model will be used to study the aging human B cell response to PPS 4 and 14 in a controlled cytokine environment allowing us to differentiate altered response intrinsic to the B cells versus altered responses secondary to environmental factors such as cytokines. The results of these studies will form the essential baseline for the rational development of vaccine and adjuvant strategies for the elderly.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG015978-01A1
Application #
6097425
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Premen, Andre J
Project Start
2000-04-01
Project End
2005-03-31
Budget Start
2000-04-01
Budget End
2001-03-31
Support Year
1
Fiscal Year
2000
Total Cost
$205,000
Indirect Cost
Name
University of Toledo
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
807418939
City
Toledo
State
OH
Country
United States
Zip Code
43614
Iyer, Anita S; Khaskhely, Noor M; Leggat, David J et al. (2016) Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults. PLoS One 11:e0150261
Iyer, Anita S; Ohtola, Jennifer A; Westerink, M A Julie (2015) Age-related immune response to pneumococcal polysaccharide vaccination: lessons for the clinic. Expert Rev Vaccines 14:85-97
Leggat, David J; Thompson, Rebecca S; Khaskhely, Noor M et al. (2013) The immune response to pneumococcal polysaccharides 14 and 23F among elderly individuals consists predominantly of switched memory B cells. J Infect Dis 208:101-8
Westerink, M A Julie; Schroeder Jr, Harry W; Nahm, Moon H (2012) Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination. Aging Dis 3:51-67
Khaskhely, Noor; Mosakowski, Jason; Thompson, Rebecca S et al. (2012) Phenotypic analysis of pneumococcal polysaccharide-specific B cells. J Immunol 188:2455-63
Rabquer, Bradley; Shriner, Anne K; Smithson, S Louise et al. (2007) B cell mediated priming following pneumococcal colonization. Vaccine 25:2036-42
Shriner, Anne K; Smithson, S Louise; Rabquer, Bradley et al. (2006) Analysis of the young and elderly variable gene repertoire in response to pneumococcal polysaccharides using a reconstituted SCID mouse model. Vaccine 24:7159-66
Shriner, Anne K; Smithson, S Louise; Prinz, Deborah M et al. (2006) Comparison of the human immune response to conjugate and polysaccharide pneumococcal vaccination using a reconstituted SCID mouse model. Vaccine 24:7197-203
Rabquer, Bradley; Smithson, S Louise; Shriner, Anne et al. (2006) The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination. Immunol Lett 106:187-90
Smithson, S Louise; Kolibab, Kris; Shriner, Anne K et al. (2005) Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults: analysis of the variable light chain repertoire. Infect Immun 73:7477-84

Showing the most recent 10 out of 11 publications